chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Acute respiratory failure, COVID-19, Cryotherapy, Dyspnoea, Fatigue
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 66 yo male patient with PMH for stage IV squamous cell carcinoma on chemo, post obstructive PNA and infiltrative, friable L mainstem bronchus mass s/p endobronchial cryotherapy and excision in August 2022; hiliar, mediastinal, and R-sided supraclavicular lymphadenopathy; multiple pulmonary nodules; R-sided pleural effusion; and osteolytic lesions in addition to COPD, tobacco use, paroxysmal a fib, HTN, HLD, vitamin D deficiency, multilevel cervical degenerative disc disease, PTSD, MDD, and social phobia. Pt presented to ED on 11/08/2022 with fever, fatigue and SOB. Pt admitted on 11/8 with acute hypoxic respiratory failure, COVID 19 and secondary multifocal bacterial PNA. Pt given broad spectrum abx, cefipime and doxycycline for PNA (11/9-11/15). Pt given remdesivir (11/9-11/11) and dexamethaxone (11/9-11/15) for COVID-19. Pt given supplemental oxygen. Pt improved and hemodynamically stable. Discharged to home on 11/16/22. Other Relevant HX: 66 yo male patient with PMH for stage IV squamous cell carcinoma on chemo, post obstructive PNA and infiltrative, friable L mainstem bronchus mass s/p endobronchial cryotherapy and excision in August 2022; hiliar, mediastinal, and R-sided supraclavicular lymphadenopathy; multiple pulmonary nodules; R-sided pleural effusion; and osteolytic lesions in addition to COPD, tobacco use, paroxysmal a fib, HTN, HLD, vitamin D deficiency, multilevel cervical degenerative disc disease, PTSD, MDD, and social phobia. Other: Covid Infection w/ hospitalization
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Mass excision, Pneumonia bacterial, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 66 yo male patient with PMH for stage IV squamous cell carcinoma on chemo, post obstructive PNA and infiltrative, friable L mainstem bronchus mass s/p endobronchial cryotherapy and excision in August 2022; hiliar, mediastinal, and R-sided supraclavicular lymphadenopathy; multiple pulmonary nodules; R-sided pleural effusion; and osteolytic lesions in addition to COPD, tobacco use, paroxysmal a fib, HTN, HLD, vitamin D deficiency, multilevel cervical degenerative disc disease, PTSD, MDD, and social phobia. Pt presented to ED on 11/08/2022 with fever, fatigue and SOB. Pt admitted on 11/8 with acute hypoxic respiratory failure, COVID 19 and secondary multifocal bacterial PNA. Pt given broad spectrum abx, cefipime and doxycycline for PNA (11/9-11/15). Pt given remdesivir (11/9-11/11) and dexamethaxone (11/9-11/15) for COVID-19. Pt given supplemental oxygen. Pt improved and hemodynamically stable. Discharged to home on 11/16/22. Other Relevant HX: 66 yo male patient with PMH for stage IV squamous cell carcinoma on chemo, post obstructive PNA and infiltrative, friable L mainstem bronchus mass s/p endobronchial cryotherapy and excision in August 2022; hiliar, mediastinal, and R-sided supraclavicular lymphadenopathy; multiple pulmonary nodules; R-sided pleural effusion; and osteolytic lesions in addition to COPD, tobacco use, paroxysmal a fib, HTN, HLD, vitamin D deficiency, multilevel cervical degenerative disc disease, PTSD, MDD, and social phobia. Other: Covid Infection w/ hospitalization
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, COVID-19 pneumonia, Dyspnoea, Lethargy
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: Patient presented to ED with complaint of shortness of breath and lethargy. Admitted for acute on chronic hypoxemic/hypercarbic respiratory failure secondary to COVID pneumonia. Continued home nebulizers, methylprednisolone 20mg IV twice daily. On day 2 of admission, methylprednisolone changed to dexamethasone and remdesivir initiated. Continues to be hospitalized. Other Relevant HX: Other: COVID HOSPITALIZATION
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory failure
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: Patient presented to ED with complaint of shortness of breath and lethargy. Admitted for acute on chronic hypoxemic/hypercarbic respiratory failure secondary to COVID pneumonia. Continued home nebulizers, methylprednisolone 20mg IV twice daily. On day 2 of admission, methylprednisolone changed to dexamethasone and remdesivir initiated. Continues to be hospitalized. Other Relevant HX: Other: COVID HOSPITALIZATION
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Breakthrough COVID-19, SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10067923:VACCINE BREAKTHROUGH INFECTION; 10084355:COVID-19 VIRUS TEST POSITIVE; Narrative: hospitalization- incidental COVID positive during admission upon testing for LTAC placement Other Relevant HX: Other: hospitalization- incidental COVID positive during admission upon testing for placement
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Headache, Respiratory symptom, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Reported Symptoms: 10019211:HEADACHE; 10054112:HOSPITALISATION; 10067923:VACCINE BREAKTHROUGH INFECTION; 10078455:UPPER RESPIRATORY SYMPTOM; 10084355:COVID-19 VIRUS TEST POSITIVE; Narrative: Hospitalization- COVID positive fully vaccinated, (Admitted with headache and URI symptoms- received 2 doses of remdesivir and discharged)) Other Relevant HX: Other: Hospitalization-COVID positive fully vaccinated, Headache and URI symptoms
Age: 94.0
Sex: M
Vaccine: COVID19
Symptoms: Breakthrough COVID-19, COVID-19, SARS-CoV-2 test positive, Syncope
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10068923:VACCINE BREAKTHROUGH INFECTION; 10084355:COVID-19 VIRUS TEST POSITIVE; 10084459:ASYMPTOMATIC COVID-19; Narrative: Hospitalization- COVID positive fully vaccinated, asymptomatic (Admitted for syncope) Other Relevant HX: Other: Hospitalization- COVID positive fully vaccinated, asymptomatic
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Chronic obstructive pulmonary disease, Condition aggravated, SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms 10054112: HOSPITALISATION; 10067923: VACCINE BREAKTHROUGH INFECTION; 10004355: COVID-19 VIRUS TEST POSITIVE; Narrative:Fully vaccinated, COVID positive 3 days prior to admit. Admitted for COVID pneumonia and treated with dexamethasone then prednisone for COPD exacerbation. Also received azithromycin and ceftriaxone. Discharged home on levofloxacin, prednisone, and resumed chronic azithromycin. Other relevant HX: Other: Hospitalization -COVD positive, fully vaccinated
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccine breakthrough infection
Clinical narrative: Reported Symptoms 10054112: HOSPITALISATION; 10067923: VACCINE BREAKTHROUGH INFECTION; 10004355: COVID-19 VIRUS TEST POSITIVE; Narrative:Fully vaccinated, COVID positive 3 days prior to admit. Admitted for COVID pneumonia and treated with dexamethasone then prednisone for COPD exacerbation. Also received azithromycin and ceftriaxone. Discharged home on levofloxacin, prednisone, and resumed chronic azithromycin. Other relevant HX: Other: Hospitalization -COVD positive, fully vaccinated
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: Bladder cancer, COVID-19, Cough, Dyspnoea, Metastatic carcinoma of the bladder
Clinical narrative: Reported Symptoms: 10005003:BLADDER CANCER; 10005003:BLADDER CANCER; 10011232:COUGHING; 10011232:COUGHING; 10016558:FEVER; 10016558:FEVER; 10038678:RESPIRATORY DEPRESSION; 10038678:RESPIRATORY DEPRESSION; 1004770:VOMITING; 10047700:VOMITING; Narrative: Covid +, Moderna x 5, fever, metastatic bladder CA, sore throat, immunotherapy, cough, SOB, n/v, resp depression. tx with decadron, remdesivir, oxygen. d/c to home. Other Relevant HX: Other: metastatic bladder CA
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: Nausea, Oropharyngeal pain, Pyrexia, Respiratory depression, SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms: 10005003:BLADDER CANCER; 10005003:BLADDER CANCER; 10011232:COUGHING; 10011232:COUGHING; 10016558:FEVER; 10016558:FEVER; 10038678:RESPIRATORY DEPRESSION; 10038678:RESPIRATORY DEPRESSION; 1004770:VOMITING; 10047700:VOMITING; Narrative: Covid +, Moderna x 5, fever, metastatic bladder CA, sore throat, immunotherapy, cough, SOB, n/v, resp depression. tx with decadron, remdesivir, oxygen. d/c to home. Other Relevant HX: Other: metastatic bladder CA
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: Vomiting
Clinical narrative: Reported Symptoms: 10005003:BLADDER CANCER; 10005003:BLADDER CANCER; 10011232:COUGHING; 10011232:COUGHING; 10016558:FEVER; 10016558:FEVER; 10038678:RESPIRATORY DEPRESSION; 10038678:RESPIRATORY DEPRESSION; 1004770:VOMITING; 10047700:VOMITING; Narrative: Covid +, Moderna x 5, fever, metastatic bladder CA, sore throat, immunotherapy, cough, SOB, n/v, resp depression. tx with decadron, remdesivir, oxygen. d/c to home. Other Relevant HX: Other: metastatic bladder CA
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute myocardial infarction, Anticoagulation drug level below therapeutic, COVID-19, Chest pain, Cough
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 76 yo male patient with past medical history for coronary artery disease (inferior wall MI 1993), mitral valve regurg status post mitral valve replacement 2014 on warfarin, heart failure with reduced ejection fraction 30 to 35% with AICD and hypertension presented to ED on 12/07/22 with cough and SOB. Pt reports chest pain with cough, fever and myalgias. Pt admitted to hospital for COVID-19 and Type II NSTEMI. Pt received supportive care only for COVID-19. No respiratory failure during entire stay. INR found to be subtherapeutic during course of stay and was treated. Pt improved and hemodynamically stable. Discharged to home on 12/11/22. Other Relevant HX: 76 yo male patient with past medical history for coronary artery disease (inferior wall MI 1993), mitral valve regurg status post mitral valve replacement 2014 on warfarin, heart failure with reduced ejection fraction 30 to 35% with AICD and hypertension. Other: COVID-19 Infection w/ hospitalization
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dyspnoea, Myalgia, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 76 yo male patient with past medical history for coronary artery disease (inferior wall MI 1993), mitral valve regurg status post mitral valve replacement 2014 on warfarin, heart failure with reduced ejection fraction 30 to 35% with AICD and hypertension presented to ED on 12/07/22 with cough and SOB. Pt reports chest pain with cough, fever and myalgias. Pt admitted to hospital for COVID-19 and Type II NSTEMI. Pt received supportive care only for COVID-19. No respiratory failure during entire stay. INR found to be subtherapeutic during course of stay and was treated. Pt improved and hemodynamically stable. Discharged to home on 12/11/22. Other Relevant HX: 76 yo male patient with past medical history for coronary artery disease (inferior wall MI 1993), mitral valve regurg status post mitral valve replacement 2014 on warfarin, heart failure with reduced ejection fraction 30 to 35% with AICD and hypertension. Other: COVID-19 Infection w/ hospitalization
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute myocardial infarction, COVID-19, Cardiac failure congestive, Confusional state, SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 75 yo male patent with a PMH for T2DM, bladder outlet obstruction with chronic foley with frequent UTIs, substance use, HTN, and severe visual impairment from advanced cataracts and glaucoma presented to ED on 12/07/2022 with confusion for 1 week. Pt admitted with COVID-19 positive, UTI, and NSTEMI with mild CHF. Pt received remdesivir (12/9-12/11) and supportive care. Pt improved and discharged to home on 12/18/22. Other Relevant HX: 75 yo male patient with a PMH for T2DM, bladder outlet obstruction with chronic foley with frequent UTIs, substance use, HTN, and severe visual impairment from advanced cataracts and glaucome. Other: COVID-19 Infection w/ hospitalization
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Urinary tract infection
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 75 yo male patent with a PMH for T2DM, bladder outlet obstruction with chronic foley with frequent UTIs, substance use, HTN, and severe visual impairment from advanced cataracts and glaucoma presented to ED on 12/07/2022 with confusion for 1 week. Pt admitted with COVID-19 positive, UTI, and NSTEMI with mild CHF. Pt received remdesivir (12/9-12/11) and supportive care. Pt improved and discharged to home on 12/18/22. Other Relevant HX: 75 yo male patient with a PMH for T2DM, bladder outlet obstruction with chronic foley with frequent UTIs, substance use, HTN, and severe visual impairment from advanced cataracts and glaucome. Other: COVID-19 Infection w/ hospitalization
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, COVID-19, Chest X-ray normal, Dyspnoea, Hypoxia
Clinical narrative: Reported Symptoms: 10054112; HOSPITALISATION: 1000428: COVID-19; Narrative: 76 yo male patient with PMH for mobid obesity BMI >40, restrictive lung disease on PFT, HTN and DM2 presented to ED on 12/11/22 w/ SOB and weaker for 2 days prior. Pt positive for COVID-19 and hypoxia on exertion. Admitted to hospital for further evaluation and treatment. Pt received remdesivir (12/11-12/14) and dexamethasone (12/11-12/14). Chest x-ray was unremarkable. Pt improved and was discharged to home on 12/14/2022. Dexamethasone continued upon discharge for 5 more days. Other Relevant HX: 76 yo male patient with PMH for morbid obesity BMI >40, restrictive lung disease on PPT, HTN, DM2. Other: COVID-19 infection w/ hospitalization
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms: 10054112; HOSPITALISATION: 1000428: COVID-19; Narrative: 76 yo male patient with PMH for mobid obesity BMI >40, restrictive lung disease on PFT, HTN and DM2 presented to ED on 12/11/22 w/ SOB and weaker for 2 days prior. Pt positive for COVID-19 and hypoxia on exertion. Admitted to hospital for further evaluation and treatment. Pt received remdesivir (12/11-12/14) and dexamethasone (12/11-12/14). Chest x-ray was unremarkable. Pt improved and was discharged to home on 12/14/2022. Dexamethasone continued upon discharge for 5 more days. Other Relevant HX: 76 yo male patient with PMH for morbid obesity BMI >40, restrictive lung disease on PPT, HTN, DM2. Other: COVID-19 infection w/ hospitalization
Age: 80.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, Atrial fibrillation, Blood sodium increased, COVID-19, Pain
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 81 yo male patient w/ PMH for HTN, obesity, CAD, OSA, A-fib on apixaban, HFrEF EF 20-30%, chronic hyponatremia and adrenal insufficiency presented to ED on 12/09/22 w/ worsening weakness, productive cough, rash, fever and body aches. Pt positive for COVID-19. Pt admitted to hospital on 12/10 with COVID-19 and chronic hyponatremia. Pt received supportive meds only for COVID as pt had minimal symptoms. Pt received IV furosemide and serum sodium increased. Afib w/ RVR thought to be likely exacerbated due to COVID-19 and treated with metoprolol. Pt improved and discharged to home on 12/14/22. Other Relevant HX: 81 yo male patient w/ PMH for HTN, obesity, CAD, OSA, A-fib on apixaban, HFrEF EF 20-30%, chronic hyponatremia and adrenal insufficiency. Other: COVID-19 infection w/ hospitalization
Age: 80.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Productive cough, Pyrexia, Rash, SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 81 yo male patient w/ PMH for HTN, obesity, CAD, OSA, A-fib on apixaban, HFrEF EF 20-30%, chronic hyponatremia and adrenal insufficiency presented to ED on 12/09/22 w/ worsening weakness, productive cough, rash, fever and body aches. Pt positive for COVID-19. Pt admitted to hospital on 12/10 with COVID-19 and chronic hyponatremia. Pt received supportive meds only for COVID as pt had minimal symptoms. Pt received IV furosemide and serum sodium increased. Afib w/ RVR thought to be likely exacerbated due to COVID-19 and treated with metoprolol. Pt improved and discharged to home on 12/14/22. Other Relevant HX: 81 yo male patient w/ PMH for HTN, obesity, CAD, OSA, A-fib on apixaban, HFrEF EF 20-30%, chronic hyponatremia and adrenal insufficiency. Other: COVID-19 infection w/ hospitalization
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Bradycardia, COVID-19, Constipation, Dehydration, Hypophagia
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 72 yo male patient with a PMH for CAD s/p CABG in 2006, normal MPI and echo 2/2022, DM2, CKDG3b, depression/anxiety, and former alcohol use disorder presented to ED w/ N/V and episode of syncope 01/24/22. Pt COVID positive on 1/24 in ED and admitted to hospital for syncope secondary to likely multifactorial in setting of COVID positive and dehydration/possible poor PO intake with constipation. Pt did not receive treatment for COVID-19 during hospital stay and remained asymptomatic. Pt noted to have perirectal mass and periaortic lymphadenopathy concerning for carcinoma with metastases as well as fibrosis at base of lungs. Pt was also treated for constipation and bradycardia during admission. Pt stable and discharged to home on 01/28/2023. Other Relevant HX: 72 yo male patient with a PMH for CAD s/p CABG in 2006, normal MPI and echo 2/2022, DM2, CKDG3b, depression/anxiety, and former alcohol use disorder. Other: COVID Infection w/ hospitalization
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Intestinal mass, Lymphadenopathy, Nausea, Pulmonary fibrosis, SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 72 yo male patient with a PMH for CAD s/p CABG in 2006, normal MPI and echo 2/2022, DM2, CKDG3b, depression/anxiety, and former alcohol use disorder presented to ED w/ N/V and episode of syncope 01/24/22. Pt COVID positive on 1/24 in ED and admitted to hospital for syncope secondary to likely multifactorial in setting of COVID positive and dehydration/possible poor PO intake with constipation. Pt did not receive treatment for COVID-19 during hospital stay and remained asymptomatic. Pt noted to have perirectal mass and periaortic lymphadenopathy concerning for carcinoma with metastases as well as fibrosis at base of lungs. Pt was also treated for constipation and bradycardia during admission. Pt stable and discharged to home on 01/28/2023. Other Relevant HX: 72 yo male patient with a PMH for CAD s/p CABG in 2006, normal MPI and echo 2/2022, DM2, CKDG3b, depression/anxiety, and former alcohol use disorder. Other: COVID Infection w/ hospitalization
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Syncope, Vomiting
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 72 yo male patient with a PMH for CAD s/p CABG in 2006, normal MPI and echo 2/2022, DM2, CKDG3b, depression/anxiety, and former alcohol use disorder presented to ED w/ N/V and episode of syncope 01/24/22. Pt COVID positive on 1/24 in ED and admitted to hospital for syncope secondary to likely multifactorial in setting of COVID positive and dehydration/possible poor PO intake with constipation. Pt did not receive treatment for COVID-19 during hospital stay and remained asymptomatic. Pt noted to have perirectal mass and periaortic lymphadenopathy concerning for carcinoma with metastases as well as fibrosis at base of lungs. Pt was also treated for constipation and bradycardia during admission. Pt stable and discharged to home on 01/28/2023. Other Relevant HX: 72 yo male patient with a PMH for CAD s/p CABG in 2006, normal MPI and echo 2/2022, DM2, CKDG3b, depression/anxiety, and former alcohol use disorder. Other: COVID Infection w/ hospitalization
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, COVID-19, Cough, Dizziness, Dyspnoea exertional
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 71 yo male patient w/ PMH for Alzeimer's dementia, DM2, HTN, HLD, CAD, s/p PCI 04/22, Obesity, and OSA brought to ED by son on 01/03/2023 w/ general weakness, recent falls and inablity to take care of himself. Pt reported having dizziness and dyspnea upon exertion in addition to a non-productive cough. Pt positive for COVID-19 in ED. Pt admitted to hospital for further evaluation and treatment. Pt received dexamethasone (01/03-01/10) and remdesivir (01/04-01/08). Echo showed LVEF <20 %. Pt had PCI and 1 DES placed on 1/18. Pt started on new medications including clopidogrel, spironolactone, furosemide, and metorolol succinate. Pt improved and discharged to home on 01/13/2023. Other Relevant HX: 71 yo male patient w/ PMH for Alzheimer's dementia, DM2, HTN, HLD, Obesity, and OSA. Other: Other: COVID Infection w/ hospitalization
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Echocardiogram abnormal, Ejection fraction decreased, Fall, Loss of personal independence in daily activities, SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 71 yo male patient w/ PMH for Alzeimer's dementia, DM2, HTN, HLD, CAD, s/p PCI 04/22, Obesity, and OSA brought to ED by son on 01/03/2023 w/ general weakness, recent falls and inablity to take care of himself. Pt reported having dizziness and dyspnea upon exertion in addition to a non-productive cough. Pt positive for COVID-19 in ED. Pt admitted to hospital for further evaluation and treatment. Pt received dexamethasone (01/03-01/10) and remdesivir (01/04-01/08). Echo showed LVEF <20 %. Pt had PCI and 1 DES placed on 1/18. Pt started on new medications including clopidogrel, spironolactone, furosemide, and metorolol succinate. Pt improved and discharged to home on 01/13/2023. Other Relevant HX: 71 yo male patient w/ PMH for Alzheimer's dementia, DM2, HTN, HLD, Obesity, and OSA. Other: Other: COVID Infection w/ hospitalization
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: Asthenia, Atrial fibrillation, COVID-19, Cough, Fall
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION: 10084268:COVID-19; Narrative: 83 yo male patient w/ PMH for Parkinson disease with autonomic dysfunction/orthostatic hypotension and HLD presented to ED on 01/26/2023 w/ 5 days of cough, fatigue, weakness, and a recent fall. Pt found to be COVID-19 positive, new onset Afib, and symptomatic hypokalemia. Pt admitted to hospital for further evaluation and treatment. Pt received supportive medications for COVID-19. Pt improved and discharged to home on 01/20/2023. Other Relevant HX: 83 yo male patient w/ PMH for Parkinson disease with autonomic dysfunction/orthostatic hypotension and HLD. Other Covid Infection w/ hospitalization
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: Fatigue, Hypokalaemia, SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION: 10084268:COVID-19; Narrative: 83 yo male patient w/ PMH for Parkinson disease with autonomic dysfunction/orthostatic hypotension and HLD presented to ED on 01/26/2023 w/ 5 days of cough, fatigue, weakness, and a recent fall. Pt found to be COVID-19 positive, new onset Afib, and symptomatic hypokalemia. Pt admitted to hospital for further evaluation and treatment. Pt received supportive medications for COVID-19. Pt improved and discharged to home on 01/20/2023. Other Relevant HX: 83 yo male patient w/ PMH for Parkinson disease with autonomic dysfunction/orthostatic hypotension and HLD. Other Covid Infection w/ hospitalization
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Computerised tomogram thorax abnormal, Delirium, Gastrointestinal tube insertion, Hypophagia
Clinical narrative: Reported Symptoms:  10054112:HOSPITALISATION; 10084268: COVID-19;   Narrative:  74 yo male patient with PMH for A. fib/flutter on apixaban, CAD, HFpEF, pulmonary embolism, SSS s/p PPM, schizoaffective disorder, tardive dyskinesia, and dementia presented to ED on 12/11/2022 from group with decreased oral intake.  Pt had tested positive for COVID-19 on 12/08 and started on dexamethasone and molnupiravir at that time. Pt positive for influenza in ED. Pt admitted to hospital for concern for hypoxic respiratory failure secondary to viral/bacterial PNA.  Pt received oseltamivir (12/12-12/14, pt refused on 12/15).  Pt received dexamethasone (12/12-12/13, pt refused on 12/14). Dexamethasone discontinued on 12/14 as pt was on room air and COVID-19 infection mild, steroids thought to be contributing to delirium and altered mental status. IV antibiotics for CAP coverage stopped on 12/14. IV Zosyn given in ED (12/11), changed to IV unasyn (12/12), changed to levofloxacin (12/12), changed to ceftriaxone (12/13).  Duotube was placed and feeding started.  Pt much improved and duotube discontinued on 12/22.  Pt maintained good oral intake.  Pt stable and discharged back to LTC on 12/23.  Other Relevant HX:  74 y/o male patient with PMH for A. fib/flutter on apixaban, CAD, HFpEF, pulmonary embolism, SSS s/p PPM, schizoaffective disorder, tardive dyskinesia, and dementia.  Other: Covid Infection w/ hospitalization
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Influenza virus test positive, Lung consolidation, Mental status changes, Pleural effusion, SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms:  10054112:HOSPITALISATION; 10084268: COVID-19;   Narrative:  74 yo male patient with PMH for A. fib/flutter on apixaban, CAD, HFpEF, pulmonary embolism, SSS s/p PPM, schizoaffective disorder, tardive dyskinesia, and dementia presented to ED on 12/11/2022 from group with decreased oral intake.  Pt had tested positive for COVID-19 on 12/08 and started on dexamethasone and molnupiravir at that time. Pt positive for influenza in ED. Pt admitted to hospital for concern for hypoxic respiratory failure secondary to viral/bacterial PNA.  Pt received oseltamivir (12/12-12/14, pt refused on 12/15).  Pt received dexamethasone (12/12-12/13, pt refused on 12/14). Dexamethasone discontinued on 12/14 as pt was on room air and COVID-19 infection mild, steroids thought to be contributing to delirium and altered mental status. IV antibiotics for CAP coverage stopped on 12/14. IV Zosyn given in ED (12/11), changed to IV unasyn (12/12), changed to levofloxacin (12/12), changed to ceftriaxone (12/13).  Duotube was placed and feeding started.  Pt much improved and duotube discontinued on 12/22.  Pt maintained good oral intake.  Pt stable and discharged back to LTC on 12/23.  Other Relevant HX:  74 y/o male patient with PMH for A. fib/flutter on apixaban, CAD, HFpEF, pulmonary embolism, SSS s/p PPM, schizoaffective disorder, tardive dyskinesia, and dementia.  Other: Covid Infection w/ hospitalization
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Fatigue, Mental status changes, SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10067923:VACCINE BREAKTHROUGH INFECTION; 10084355:COVID-19 VIRUS TEST POSITIVE; Narrative: 75 year old male with metastatic urothelial cancer (mets to liver) and illeal conduit who presented to the ER from his SNF due to worsening fatigue and reported changed in mental status. He was found to be COVID positive on admission in setting of fully vaccinated status. Other Relevant HX: 75 year old male with metastatic urothelial cancer (mets to liver) and illeal conduit who presented to the ER from his SNF due to worsening fatigue and reported changed in mental status. He was found to be COVID positive on admission in setting of fully vaccinated status. Other: Hospitalization: COVID positive; fully vaccinated
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19, COVID19-2
Symptoms: Asthenia, COVID-19, Condition aggravated, Hypoxia, Influenza
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 76 yo male patient with PMH for CAD s/p drug-eluting stent to RCA in 2014, pacemaker, CKD stage 3a, prostate cancer, DM2, HLD, and obesity presented to ED on 12/02/2023 with difficultly getting out of bed and feeling overall weak. Pt noted to have hypoxemia, worsening renal insufficiency, prostate CA, and weakness. Pt admitted for further evaluation and treatment. Pt tested positive for COVID-19 and Influenza A on 12/03/2022. Pt received supplemental O2, remdesivir (12/4-12/8) and dexamethasone (12/4-12/8) for COVID and oseltamavir (12/3-12/8) for flu. Throughout hospital course, pt continued to improve. Patient stable and discharged to home with family on 12/10/22. Other Relevant HX: 75 yo male patient with PMH for CAD s/p drug-eluting stent to RCA in 2014, pacemaker, CKD stage 3a, prostate cancer, DM2, HLD, and obesity. Other: Covid Infection w/ hospitalization
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19, COVID19-2
Symptoms: Influenza A virus test positive, Mobility decreased, Prostate cancer, Renal failure, SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 76 yo male patient with PMH for CAD s/p drug-eluting stent to RCA in 2014, pacemaker, CKD stage 3a, prostate cancer, DM2, HLD, and obesity presented to ED on 12/02/2023 with difficultly getting out of bed and feeling overall weak. Pt noted to have hypoxemia, worsening renal insufficiency, prostate CA, and weakness. Pt admitted for further evaluation and treatment. Pt tested positive for COVID-19 and Influenza A on 12/03/2022. Pt received supplemental O2, remdesivir (12/4-12/8) and dexamethasone (12/4-12/8) for COVID and oseltamavir (12/3-12/8) for flu. Throughout hospital course, pt continued to improve. Patient stable and discharged to home with family on 12/10/22. Other Relevant HX: 75 yo male patient with PMH for CAD s/p drug-eluting stent to RCA in 2014, pacemaker, CKD stage 3a, prostate cancer, DM2, HLD, and obesity. Other: Covid Infection w/ hospitalization
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Cardiac telemetry abnormal, Chest discomfort, Chills, Dizziness
Clinical narrative: Reported Symptoms:  10054112:HOSPITALISATION;  10064268;COVID-19;     Narrative:  77 yo male patient with a PMH for HTN, HLD, PTSD, macular degeneration and vertigo/light headedness spells for years presented to ED on 01/01/2023 w/ presyncope vs syncope earlier that morning. Pt reported feeling warm and while trying to check his temperature he had fallen to the ground after a wave of warmth rushed over him.  Pt tested positive for COVID-19 and was admitted to hospital for COVID and syncope.  Pt was monitored on telemetry overnight.  Some sinus tachycardia in low 100s bpm noted though otherwise unremarkable.  He did not have any further episodes of chills, warm waves, light headedness or chest discomfort/palpitations.  Pt did not receive any medications for COVID.  Pt improved and was returned to his usual state of health.  Discharged to home on 01/02/2023.  A Holter Monitor was also ordered. Other Relevant HX: 77 yo male patient with a PMH for HTN, HLD, PTSD, macular degneration and vertigo/light headedness spells for years.  Other:  Covid Infection w/ hospitalization
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fall, Feeling hot, Palpitations, Presyncope, SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms:  10054112:HOSPITALISATION;  10064268;COVID-19;     Narrative:  77 yo male patient with a PMH for HTN, HLD, PTSD, macular degeneration and vertigo/light headedness spells for years presented to ED on 01/01/2023 w/ presyncope vs syncope earlier that morning. Pt reported feeling warm and while trying to check his temperature he had fallen to the ground after a wave of warmth rushed over him.  Pt tested positive for COVID-19 and was admitted to hospital for COVID and syncope.  Pt was monitored on telemetry overnight.  Some sinus tachycardia in low 100s bpm noted though otherwise unremarkable.  He did not have any further episodes of chills, warm waves, light headedness or chest discomfort/palpitations.  Pt did not receive any medications for COVID.  Pt improved and was returned to his usual state of health.  Discharged to home on 01/02/2023.  A Holter Monitor was also ordered. Other Relevant HX: 77 yo male patient with a PMH for HTN, HLD, PTSD, macular degneration and vertigo/light headedness spells for years.  Other:  Covid Infection w/ hospitalization
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Sinus tachycardia, Syncope
Clinical narrative: Reported Symptoms:  10054112:HOSPITALISATION;  10064268;COVID-19;     Narrative:  77 yo male patient with a PMH for HTN, HLD, PTSD, macular degeneration and vertigo/light headedness spells for years presented to ED on 01/01/2023 w/ presyncope vs syncope earlier that morning. Pt reported feeling warm and while trying to check his temperature he had fallen to the ground after a wave of warmth rushed over him.  Pt tested positive for COVID-19 and was admitted to hospital for COVID and syncope.  Pt was monitored on telemetry overnight.  Some sinus tachycardia in low 100s bpm noted though otherwise unremarkable.  He did not have any further episodes of chills, warm waves, light headedness or chest discomfort/palpitations.  Pt did not receive any medications for COVID.  Pt improved and was returned to his usual state of health.  Discharged to home on 01/02/2023.  A Holter Monitor was also ordered. Other Relevant HX: 77 yo male patient with a PMH for HTN, HLD, PTSD, macular degneration and vertigo/light headedness spells for years.  Other:  Covid Infection w/ hospitalization
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute respiratory failure, COVID-19, Chills, Chronic obstructive pulmonary disease, Condition aggravated
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 65 yo male patient with past medical history significant for colon cancer status post hemicolectomy/chemo, MGU5, HLD, HTN smoking, and BPH presented to ED on 12/04/2022 with complaint of cough congestion sputum for a month. Pt reports some fevers and chills. Pt with acute hypoxic respiratory infection, COVID-19, hypokalemia and COPD exacerbation. In the ED, given 2L normal saline, KCl IV, magnesium and dexamethasone. Pt admitted to hospital on 12/5 for further evaluation and treatment. Pt received supplemental 02 and remdesivir (12/5-12/6). Pt declined further inpatient treatment and did not want remdesivir. Pt received dexamethasone (12/5-12/6) and transitioned to prednisone to complete 5 days course for suspected COPD exacerbation. Pt oxgenation improved on day 2 and on room air. Pt requested to go home as he felt he was at baseline. Pt discharged to home on 12/6/22. Other Relevant HX: 65 yo male patient with past medical history significant for colon cancer status post hemicolectomy/chemo, MGU5, HLD, HTN, smoking, and BPH. Other: COVID Infection w/ hospitalization
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cough, Hypokalaemia, Productive cough, Pyrexia, Respiratory tract congestion
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 65 yo male patient with past medical history significant for colon cancer status post hemicolectomy/chemo, MGU5, HLD, HTN smoking, and BPH presented to ED on 12/04/2022 with complaint of cough congestion sputum for a month. Pt reports some fevers and chills. Pt with acute hypoxic respiratory infection, COVID-19, hypokalemia and COPD exacerbation. In the ED, given 2L normal saline, KCl IV, magnesium and dexamethasone. Pt admitted to hospital on 12/5 for further evaluation and treatment. Pt received supplemental 02 and remdesivir (12/5-12/6). Pt declined further inpatient treatment and did not want remdesivir. Pt received dexamethasone (12/5-12/6) and transitioned to prednisone to complete 5 days course for suspected COPD exacerbation. Pt oxgenation improved on day 2 and on room air. Pt requested to go home as he felt he was at baseline. Pt discharged to home on 12/6/22. Other Relevant HX: 65 yo male patient with past medical history significant for colon cancer status post hemicolectomy/chemo, MGU5, HLD, HTN, smoking, and BPH. Other: COVID Infection w/ hospitalization
Age: 64.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 65 yo male patient with past medical history significant for colon cancer status post hemicolectomy/chemo, MGU5, HLD, HTN smoking, and BPH presented to ED on 12/04/2022 with complaint of cough congestion sputum for a month. Pt reports some fevers and chills. Pt with acute hypoxic respiratory infection, COVID-19, hypokalemia and COPD exacerbation. In the ED, given 2L normal saline, KCl IV, magnesium and dexamethasone. Pt admitted to hospital on 12/5 for further evaluation and treatment. Pt received supplemental 02 and remdesivir (12/5-12/6). Pt declined further inpatient treatment and did not want remdesivir. Pt received dexamethasone (12/5-12/6) and transitioned to prednisone to complete 5 days course for suspected COPD exacerbation. Pt oxgenation improved on day 2 and on room air. Pt requested to go home as he felt he was at baseline. Pt discharged to home on 12/6/22. Other Relevant HX: 65 yo male patient with past medical history significant for colon cancer status post hemicolectomy/chemo, MGU5, HLD, HTN, smoking, and BPH. Other: COVID Infection w/ hospitalization
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Blood creatinine normal, Blood culture, Blood lactic acid, Blood sodium decreased
Clinical narrative: Reported Symptoms:  10011232: COUGHING;  10016558:FEVER; 10039100:RHINORRHEA;  10052251:RESPIRATORY TRACT CONGESTION;     Narrative:  2/16/23 - Pt called facility to report he tested COVID + on 2/9/23 at urgent care facility. Pt was prescribed: doxycycline, benzonatate, prednisone, and albuterol inhaler.  Pt noted improvement until fever returned, productive cough, and weakness still present.  2/16/23 Pt seen via Virtual Clinic Visit. Pt c/o cough and chest congestion.  Pt's symptoms improved for the five days post medication initiation, but for past two days he has developed increasing chest congestion and cough.  He has low grade fever that responds to Tylenol.  Denies SOB.  He is still testing positive for COVID.  Pt instructed to go to facility for face to face evaluation d/t worsening symptoms.  2/17/23 at 10:51am - Pt presented to ED for treatment.  Pt with productive cough, fever, and runny nose.  Pt denies dyspnea.  In ED, vital signs unremarkable, afebrile, 02 sat 100% on room air.   WBC 7.1. Sodium 131, creatinine 1.1, BMP unremarkable otherwise.  Lactic acid 1.0.  Patient given 1 L IV fluid, acetaminophen.   Chest x-ray showing pulmonary infiltrates throughout the right lung and to lesser degree left lower lung,  possible pneumonia.   MEDICAL DECISION MAKING (MDM):   Labs show that the patient is still COVID-positive, but also has hyponatremia.   Patient was given normal saline in the ED.   Chest x-ray shows   patchy infiltrates in the entire right lung and in the left lower lobe as   well.  His pneumonia is likely viral, so blood cultures drawn (antibiotics not
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Breath sounds abnormal, COVID-19, Chest X-ray abnormal, Hyponatraemia, Lung infiltration
Clinical narrative: Reported Symptoms:  10011232: COUGHING;  10016558:FEVER; 10039100:RHINORRHEA;  10052251:RESPIRATORY TRACT CONGESTION;     Narrative:  2/16/23 - Pt called facility to report he tested COVID + on 2/9/23 at urgent care facility. Pt was prescribed: doxycycline, benzonatate, prednisone, and albuterol inhaler.  Pt noted improvement until fever returned, productive cough, and weakness still present.  2/16/23 Pt seen via Virtual Clinic Visit. Pt c/o cough and chest congestion.  Pt's symptoms improved for the five days post medication initiation, but for past two days he has developed increasing chest congestion and cough.  He has low grade fever that responds to Tylenol.  Denies SOB.  He is still testing positive for COVID.  Pt instructed to go to facility for face to face evaluation d/t worsening symptoms.  2/17/23 at 10:51am - Pt presented to ED for treatment.  Pt with productive cough, fever, and runny nose.  Pt denies dyspnea.  In ED, vital signs unremarkable, afebrile, 02 sat 100% on room air.   WBC 7.1. Sodium 131, creatinine 1.1, BMP unremarkable otherwise.  Lactic acid 1.0.  Patient given 1 L IV fluid, acetaminophen.   Chest x-ray showing pulmonary infiltrates throughout the right lung and to lesser degree left lower lung,  possible pneumonia.   MEDICAL DECISION MAKING (MDM):   Labs show that the patient is still COVID-positive, but also has hyponatremia.   Patient was given normal saline in the ED.   Chest x-ray shows   patchy infiltrates in the entire right lung and in the left lower lobe as   well.  His pneumonia is likely viral, so blood cultures drawn (antibiotics not
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Pneumonia viral, Productive cough, Pyrexia, Rales, Respiratory tract congestion
Clinical narrative: Reported Symptoms:  10011232: COUGHING;  10016558:FEVER; 10039100:RHINORRHEA;  10052251:RESPIRATORY TRACT CONGESTION;     Narrative:  2/16/23 - Pt called facility to report he tested COVID + on 2/9/23 at urgent care facility. Pt was prescribed: doxycycline, benzonatate, prednisone, and albuterol inhaler.  Pt noted improvement until fever returned, productive cough, and weakness still present.  2/16/23 Pt seen via Virtual Clinic Visit. Pt c/o cough and chest congestion.  Pt's symptoms improved for the five days post medication initiation, but for past two days he has developed increasing chest congestion and cough.  He has low grade fever that responds to Tylenol.  Denies SOB.  He is still testing positive for COVID.  Pt instructed to go to facility for face to face evaluation d/t worsening symptoms.  2/17/23 at 10:51am - Pt presented to ED for treatment.  Pt with productive cough, fever, and runny nose.  Pt denies dyspnea.  In ED, vital signs unremarkable, afebrile, 02 sat 100% on room air.   WBC 7.1. Sodium 131, creatinine 1.1, BMP unremarkable otherwise.  Lactic acid 1.0.  Patient given 1 L IV fluid, acetaminophen.   Chest x-ray showing pulmonary infiltrates throughout the right lung and to lesser degree left lower lung,  possible pneumonia.   MEDICAL DECISION MAKING (MDM):   Labs show that the patient is still COVID-positive, but also has hyponatremia.   Patient was given normal saline in the ED.   Chest x-ray shows   patchy infiltrates in the entire right lung and in the left lower lobe as   well.  His pneumonia is likely viral, so blood cultures drawn (antibiotics not
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test positive, White blood cell count normal
Clinical narrative: Reported Symptoms:  10011232: COUGHING;  10016558:FEVER; 10039100:RHINORRHEA;  10052251:RESPIRATORY TRACT CONGESTION;     Narrative:  2/16/23 - Pt called facility to report he tested COVID + on 2/9/23 at urgent care facility. Pt was prescribed: doxycycline, benzonatate, prednisone, and albuterol inhaler.  Pt noted improvement until fever returned, productive cough, and weakness still present.  2/16/23 Pt seen via Virtual Clinic Visit. Pt c/o cough and chest congestion.  Pt's symptoms improved for the five days post medication initiation, but for past two days he has developed increasing chest congestion and cough.  He has low grade fever that responds to Tylenol.  Denies SOB.  He is still testing positive for COVID.  Pt instructed to go to facility for face to face evaluation d/t worsening symptoms.  2/17/23 at 10:51am - Pt presented to ED for treatment.  Pt with productive cough, fever, and runny nose.  Pt denies dyspnea.  In ED, vital signs unremarkable, afebrile, 02 sat 100% on room air.   WBC 7.1. Sodium 131, creatinine 1.1, BMP unremarkable otherwise.  Lactic acid 1.0.  Patient given 1 L IV fluid, acetaminophen.   Chest x-ray showing pulmonary infiltrates throughout the right lung and to lesser degree left lower lung,  possible pneumonia.   MEDICAL DECISION MAKING (MDM):   Labs show that the patient is still COVID-positive, but also has hyponatremia.   Patient was given normal saline in the ED.   Chest x-ray shows   patchy infiltrates in the entire right lung and in the left lower lobe as   well.  His pneumonia is likely viral, so blood cultures drawn (antibiotics not
Age: 53.0
Sex: M
Vaccine: PNC20
Symptoms: Anaphylactic reaction, Hypotension, Pruritus, Skin lesion, Swelling
Clinical narrative: Reported Symptoms:  10002218:ANAPHYLAXIS; 10021097:HYPOTENSION; 10037007:PRURITUS; Narrative: Patient received TDAP and Prevar 20 on 02/15/23. Two days later he noticed raised welts on his arms. Next day, the raised lesions increased throughout his body with my welts on the R side. He drove to the ED on 02/17/23. In the ED, he was hypotensive (SBP in 605) with swelling. Improved after dexamethasone, diphenhydramine, famotidien and epi x 2. Other Relevant HX:  Other:
Age: 53.0
Sex: M
Vaccine: PNC20
Symptoms: Urticaria
Clinical narrative: Reported Symptoms:  10002218:ANAPHYLAXIS; 10021097:HYPOTENSION; 10037007:PRURITUS; Narrative: Patient received TDAP and Prevar 20 on 02/15/23. Two days later he noticed raised welts on his arms. Next day, the raised lesions increased throughout his body with my welts on the R side. He drove to the ED on 02/17/23. In the ED, he was hypotensive (SBP in 605) with swelling. Improved after dexamethasone, diphenhydramine, famotidien and epi x 2. Other Relevant HX:  Other:
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal pain lower, Acute respiratory failure, Asthenia, COVID-19, Chest pain
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 82 yo male patient with PMH for COPD on home 02 @2L/min, CAD s/p remote CABG, and HTN presented to ED on 11/22/22 with increasing general weakness, abdominal pain, cough and CP all associated with the coughing. Pt has chronic CP, more exertional and responds to NTG and reports this has not changed. Reported productive cough of whitish phlegm and low grade fever/chills. Pt arrived to ED without his 02 and sats at 87% per ED report and abdominal pain of different character (now all lower abdomen). Pt tested positive for COVID-19 about 6 days prior and took Paxlovid 4 days prior for only 2 days and stopped due to weakness, no appetite and unable to drink enough fluid. Also, had been using diaper for few days prior due to urgency to defecate. Pt w/ elevated D-dimer, elevated procalcitonin with leukocytosis of 22K. Pt admitted for COVID-19 w/ acute on chronic hypoxemic respiratory failure. Pt received remdesivir (11/23-11/26), dexamethasone (11/23-11/29) and azithromycin (11/23-11/27). Pt also treated for colitis during admission with metronidazole. Pt weaned to home rate of O2. Pt improved and discharged to home on 11/29/22. Other Relevant HX: 82 yo male patient with PMH for COPD on home 02 @2L/min, CAD s/p remote CABG, and HTN. Other: Covid Infection w/ hospitalization